Other Species / Isoforms
  TRA2B (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsDsGEQNY
Upstream
0 34
Treatment
  • EGF
  • U0126
TRA2B (human) ______MsDsGEQNY S2-p
TRA2B iso3 (human) gap -
TRA2B (mouse) ______MsDsGEQNY S2-p
TRA2B (rat) ______MsDsGEQNY S2-p
S4-p
____MsDsGEQNYGE
0 15
TRA2B (human) ____MsDsGEQNYGE S4-p
TRA2B iso3 (human) gap -
TRA2B (mouse) ____MsDsGEQNYGE S4-p
TRA2B (rat) ____MsDsGEQNYGE S4-p
S14-p
QNYGEREsRsAsRsG
Upstream
0 36
Treatment
  • EGF
  • MG132_withdrawal
  • nocodazole
  • SII_angiotensin_2
  • U0126
TRA2B (human) QNYGEREsRsAsRsG S14-p
TRA2B iso3 (human) gap -
TRA2B (mouse) QNYGEREsRsAsRSG S14-p
TRA2B (rat) QNYGEREsRSASRSG S14-p
S16-p
YGEREsRsAsRsGsA
Upstream
0 8
Treatment
  • SII_angiotensin_2
TRA2B (human) YGEREsRsAsRsGsA S16-p
TRA2B iso3 (human) gap -
TRA2B (mouse) YGEREsRsAsRSGSA S16-p
TRA2B (rat) YGEREsRSASRSGSA S16
S18-p
EREsRsAsRsGsAHG
Upstream
0 5
Treatment
  • SII_angiotensin_2
TRA2B (human) EREsRsAsRsGsAHG S18-p
TRA2B iso3 (human) gap -
TRA2B (mouse) EREsRsAsRSGSAHG S18-p
TRA2B (rat) EREsRSASRSGSAHG S18
S20-p
EsRsAsRsGsAHGsG
0 1
TRA2B (human) EsRsAsRsGsAHGsG S20-p
TRA2B iso3 (human) gap -
TRA2B (mouse) EsRsAsRSGSAHGSG S20
TRA2B (rat) EsRSASRSGSAHGSG S20
S22-p
RsAsRsGsAHGsGKs
0 1
TRA2B (human) RsAsRsGsAHGsGKs S22-p
TRA2B iso3 (human) gap -
TRA2B (mouse) RsAsRSGSAHGSGKs S22
TRA2B (rat) RSASRSGSAHGSGKs S22
S26-p
RsGsAHGsGKsARHt
0 2
TRA2B (human) RsGsAHGsGKsARHt S26-p
TRA2B iso3 (human) gap -
TRA2B (mouse) RSGSAHGSGKsARHt S26
TRA2B (rat) RSGSAHGSGKsARHt S26
S29-p
sAHGsGKsARHtPAR
0 14
TRA2B (human) sAHGsGKsARHtPAR S29-p
TRA2B iso3 (human) gap -
TRA2B (mouse) SAHGSGKsARHtPAR S29-p
TRA2B (rat) SAHGSGKsARHtPAR S29-p
T33-p
sGKsARHtPARsRsK
Upstream
0 20
Treatment
  • nocodazole
TRA2B (human) sGKsARHtPARsRsK T33-p
TRA2B iso3 (human) gap -
TRA2B (mouse) SGKsARHtPARsRsK T33-p
TRA2B (rat) SGKsARHtPARsRSK T33-p
S37-p
ARHtPARsRsKEDSR
Upstream
0 11
Treatment
  • nocodazole
TRA2B (human) ARHtPARsRsKEDSR S37-p
TRA2B iso3 (human) gap -
TRA2B (mouse) ARHtPARsRsKEDSR S37-p
TRA2B (rat) ARHtPARsRSKEDSR S37-p
S39-p
HtPARsRsKEDSRRS
Upstream
0 4
Treatment
  • nocodazole
TRA2B (human) HtPARsRsKEDSRRS S39-p
TRA2B iso3 (human) gap -
TRA2B (mouse) HtPARsRsKEDSRRS S39-p
TRA2B (rat) HtPARsRSKEDSRRS S39
S50
SRRSRSKSRSRSESR
0 1
TRA2B (human) SRRSRSKSRSRSESR S50
TRA2B iso3 (human) gap -
TRA2B (mouse) SRRSRSKsRsRsEsR S50-p
TRA2B (rat) SRRSRSKSRSRSESR S50
S52
RSRSKSRSRSESRSR
0 1
TRA2B (human) RSRSKSRSRSESRSR S52
TRA2B iso3 (human) gap -
TRA2B (mouse) RSRSKsRsRsEsRSR S52-p
TRA2B (rat) RSRSKSRSRSESRSR S52
S54
RSKSRSRSESRSRSR
0 1
TRA2B (human) RSKSRSRSESRSRSR S54
TRA2B iso3 (human) gap -
TRA2B (mouse) RSKsRsRsEsRSRSR S54-p
TRA2B (rat) RSKSRSRSESRSRSR S54
S56
KSRSRSESRSRSRRS
0 1
TRA2B (human) KSRSRSESRSRSRRS S56
TRA2B iso3 (human) gap -
TRA2B (mouse) KsRsRsEsRSRSRRS S56-p
TRA2B (rat) KSRSRSESRSRSRRS S56
T69-p
RSSRRHYtRsRSRSR
Upstream
0 8
Treatment
  • nocodazole
TRA2B (human) RSSRRHYtRsRSRSR T69-p
TRA2B iso3 (human) gap -
TRA2B (mouse) RSSRRHYtRsRsRSR T69-p
TRA2B (rat) RSSRRHYtRsRSRSR T69-p
S71-p
SRRHYtRsRSRSRSH
Upstream
0 8
Treatment
  • nocodazole
TRA2B (human) SRRHYtRsRSRSRSH S71-p
TRA2B iso3 (human) gap -
TRA2B (mouse) SRRHYtRsRsRSRSH S71-p
TRA2B (rat) SRRHYtRsRSRSRSH S71-p
S73
RHYtRsRSRSRSHRR
0 1
TRA2B (human) RHYtRsRSRSRSHRR S73
TRA2B iso3 (human) gap -
TRA2B (mouse) RHYtRsRsRSRSHRR S73-p
TRA2B (rat) RHYtRsRSRSRSHRR S73
S81-p
RSRSHRRsRsRsysR
0 6
TRA2B (human) RSRSHRRsRsRsysR S81-p
TRA2B iso3 (human) gap -
TRA2B (mouse) RSRSHRRsRsRsysR S81-p
TRA2B (rat) RSRSHRRSRSRSYsR S81
S83-p
RSHRRsRsRsysRDY
0 17
TRA2B (human) RSHRRsRsRsysRDY S83-p
TRA2B iso3 (human) gap -
TRA2B (mouse) RSHRRsRsRsysRDY S83-p
TRA2B (rat) RSHRRSRSRSYsRDY S83
S85-p
HRRsRsRsysRDYRR
0 18
TRA2B (human) HRRsRsRsysRDYRR S85-p
TRA2B iso3 (human) gap -
TRA2B (mouse) HRRsRsRsysRDYRR S85-p
TRA2B (rat) HRRSRSRSYsRDYRR S85
Y86-p
RRsRsRsysRDYRRR
0 5
TRA2B (human) RRsRsRsysRDYRRR Y86-p
TRA2B iso3 (human) gap -
TRA2B (mouse) RRsRsRsysRDYRRR Y86-p
TRA2B (rat) RRSRSRSYsRDYRRR Y86
S87-p
RsRsRsysRDYRRRH
0 18
TRA2B (human) RsRsRsysRDYRRRH S87-p
TRA2B iso3 (human) gap -
TRA2B (mouse) RsRsRsysRDYRRRH S87-p
TRA2B (rat) RSRSRSYsRDYRRRH S87-p
S95-p
RDYRRRHsHsHsPMs
Upstream
0 180
Treatment
  • nocodazole
TRA2B (human) RDYRRRHsHsHsPMs S95-p
TRA2B iso3 (human) gap -
TRA2B (mouse) RDYRRRHsHsHsPMs S95-p
TRA2B (rat) RDYRRRHsHsHsPMS S95-p
S97-p
YRRRHsHsHsPMstR
Upstream
0 178
Treatment
  • EGF
  • nocodazole
  • SB202190
TRA2B (human) YRRRHsHsHsPMstR S97-p
TRA2B iso3 (human) gap -
TRA2B (mouse) YRRRHsHsHsPMstR S97-p
TRA2B (rat) YRRRHsHsHsPMSTR S97-p
S99-p
RRHsHsHsPMstRRR
Upstream
0 182
Treatment
  • metastatic potential
  • nocodazole
TRA2B (human) RRHsHsHsPMstRRR S99-p
TRA2B iso3 (human) gap -
TRA2B (mouse) RRHsHsHsPMstRRR S99-p
TRA2B (rat) RRHsHsHsPMSTRRR S99-p
S102-p
sHsHsPMstRRRHVG
0 19
TRA2B (human) sHsHsPMstRRRHVG S102-p
TRA2B iso3 (human) ______MSTRRRHVG S2
TRA2B (mouse) sHsHsPMstRRRHVG S102-p
TRA2B (rat) sHsHsPMSTRRRHVG S102
T103-p
HsHsPMstRRRHVGN
Upstream
0 16
Treatment
  • nocodazole
TRA2B (human) HsHsPMstRRRHVGN T103-p
TRA2B iso3 (human) _____MSTRRRHVGN T3
TRA2B (mouse) HsHsPMstRRRHVGN T103-p
TRA2B (rat) HsHsPMSTRRRHVGN T103
K140
DLREVFSKYGPIADV
0 1
TRA2B (human) DLREVFSKYGPIADV K140
TRA2B iso3 (human) DLREVFSKYGPIADV K40
TRA2B (mouse) DLREVFSkYGPIADV K140-ac
TRA2B (rat) DLREVFSKYGPIADV K140
K140-ub
DLREVFSkYGPIADV
Upstream
0 36
Treatment
  • MG132
TRA2B (human) DLREVFSkYGPIADV K140-ub
TRA2B iso3 (human) DLREVFSKYGPIADV K40
TRA2B (mouse) DLREVFSkYGPIADV K140-ub
TRA2B (rat) DLREVFSKYGPIADV K140
S155-p
SIVYDQQsRRSRGFA
0 1
TRA2B (human) SIVYDQQsRRSRGFA S155-p
TRA2B iso3 (human) SIVYDQQSRRSRGFA S55
TRA2B (mouse) SIVYDQQSRRSRGFA S155
TRA2B (rat) SIVYDQQSRRSRGFA S155
K173-ub
FENVDDAkEAkERAN
0 1
TRA2B (human) FENVDDAkEAkERAN K173-ub
TRA2B iso3 (human) FENVDDAKEAKERAN K73
TRA2B (mouse) FENVDDAKEAKERAN K173
TRA2B (rat) FENVDDAKEAKERAN K173
K176-ub
VDDAkEAkERANGME
0 1
TRA2B (human) VDDAkEAkERANGME K176-ub
TRA2B iso3 (human) VDDAKEAKERANGME K76
TRA2B (mouse) VDDAKEAKERANGME K176
TRA2B (rat) VDDAKEAKERANGME K176
K197-ub
RVDFSITkRPHtPtP
Upstream
0 4
Treatment
  • MG132
  • vorinostat
TRA2B (human) RVDFSITkRPHtPtP K197-ub
TRA2B iso3 (human) RVDFSITKRPHTPTP K97
TRA2B (mouse) RVDFSITKRPHtPtP K197
TRA2B (rat) RVDFSITKRPHtPTP K197
T201-p
SITkRPHtPtPGIyM
Upstream
0 168
Treatment
  • LRRK2-IN-1
  • metastatic potential
  • nocodazole
TRA2B (human) SITkRPHtPtPGIyM T201-p
TRA2B iso3 (human) SITKRPHTPTPGIYM T101
TRA2B (mouse) SITKRPHtPtPGIYM T201-p
TRA2B (rat) SITKRPHtPTPGIYM T201-p
T203-p
TkRPHtPtPGIyMGr
Upstream
0 34
Treatment
  • nocodazole
TRA2B (human) TkRPHtPtPGIyMGr T203-p
TRA2B iso3 (human) TKRPHTPTPGIYMGR T103
TRA2B (mouse) TKRPHtPtPGIYMGR T203-p
TRA2B (rat) TKRPHtPTPGIYMGR T203
Y207-p
HtPtPGIyMGrPtyG
0 14
TRA2B (human) HtPtPGIyMGrPtyG Y207-p
TRA2B iso3 (human) HTPTPGIYMGRPTYG Y107
TRA2B (mouse) HtPtPGIYMGRPtYG Y207
TRA2B (rat) HtPTPGIYMGRPTYG Y207
R210-m1
tPGIyMGrPtyGssR
0 3
TRA2B (human) tPGIyMGrPtyGssR R210-m1
TRA2B iso3 (human) TPGIYMGRPTYGSSR R110
TRA2B (mouse) tPGIYMGRPtYGsSR R210
TRA2B (rat) TPGIYMGRPTYGSSR R210
T212-p
GIyMGrPtyGssRRR
0 13
TRA2B (human) GIyMGrPtyGssRRR T212-p
TRA2B iso3 (human) GIYMGRPTYGSSRRR T112
TRA2B (mouse) GIYMGRPtYGsSRRR T212-p
TRA2B (rat) GIYMGRPTYGSSRRR T212
Y213-p
IyMGrPtyGssRRRD
0 1
TRA2B (human) IyMGrPtyGssRRRD Y213-p
TRA2B iso3 (human) IYMGRPTYGSSRRRD Y113
TRA2B (mouse) IYMGRPtYGsSRRRD Y213
TRA2B (rat) IYMGRPTYGSSRRRD Y213
S215-p
MGrPtyGssRRRDyy
0 3
TRA2B (human) MGrPtyGssRRRDyy S215-p
TRA2B iso3 (human) MGRPTYGSSRRRDYY S115
TRA2B (mouse) MGRPtYGsSRRRDYY S215-p
TRA2B (rat) MGRPTYGSSRRRDYY S215
S216-p
GrPtyGssRRRDyyD
0 1
TRA2B (human) GrPtyGssRRRDyyD S216-p
TRA2B iso3 (human) GRPTYGSSRRRDYYD S116
TRA2B (mouse) GRPtYGsSRRRDYYD S216
TRA2B (rat) GRPTYGSSRRRDYYD S216
Y221-p
GssRRRDyyDrGyDr
0 15
TRA2B (human) GssRRRDyyDrGyDr Y221-p
TRA2B iso3 (human) GSSRRRDYYDRGYDR Y121
TRA2B (mouse) GsSRRRDYYDRGYDR Y221
TRA2B (rat) GSSRRRDYYDRGYDR Y221
Y222-p
ssRRRDyyDrGyDrG
0 13
TRA2B (human) ssRRRDyyDrGyDrG Y222-p
TRA2B iso3 (human) SSRRRDYYDRGYDRG Y122
TRA2B (mouse) sSRRRDYYDRGYDRG Y222
TRA2B (rat) SSRRRDYYDRGYDRG Y222
R224-m1
RRRDyyDrGyDrGyD
0 10
TRA2B (human) RRRDyyDrGyDrGyD R224-m1
TRA2B iso3 (human) RRRDYYDRGYDRGYD R124
TRA2B (mouse) RRRDYYDRGYDRGYD R224
TRA2B (rat) RRRDYYDRGYDRGYD R224
Y226-p
RDyyDrGyDrGyDDr
0 5
TRA2B (human) RDyyDrGyDrGyDDr Y226-p
TRA2B iso3 (human) RDYYDRGYDRGYDDR Y126
TRA2B (mouse) RDYYDRGYDRGYDDR Y226
TRA2B (rat) RDYYDRGYDRGYDDR Y226
R228-m1
yyDrGyDrGyDDrDy
0 11
TRA2B (human) yyDrGyDrGyDDrDy R228-m1
TRA2B iso3 (human) YYDRGYDRGYDDRDY R128
TRA2B (mouse) YYDRGYDRGYDDRDy R228
TRA2B (rat) YYDRGYDRGYDDRDY R228
Y230-p
DrGyDrGyDDrDyys
0 23
TRA2B (human) DrGyDrGyDDrDyys Y230-p
TRA2B iso3 (human) DRGYDRGYDDRDYYS Y130
TRA2B (mouse) DRGYDRGYDDRDyyS Y230
TRA2B (rat) DRGYDRGYDDRDYYS Y230
R233-m1
yDrGyDDrDyysrSy
0 8
TRA2B (human) yDrGyDDrDyysrSy R233-m1
TRA2B iso3 (human) YDRGYDDRDYYSRSY R133
TRA2B (mouse) YDRGYDDRDyySRSY R233
TRA2B (rat) YDRGYDDRDYYSRSY R233
Y235-p
rGyDDrDyysrSyrG
0 199
TRA2B (human) rGyDDrDyysrSyrG Y235-p
TRA2B iso3 (human) RGYDDRDYYSRSYRG Y135
TRA2B (mouse) RGYDDRDyySRSYrG Y235-p
TRA2B (rat) RGYDDRDYYSRSYrG Y235
Y236-p
GyDDrDyysrSyrGG
0 163
TRA2B (human) GyDDrDyysrSyrGG Y236-p
TRA2B iso3 (human) GYDDRDYYSRSYRGG Y136
TRA2B (mouse) GYDDRDyySRSYrGG Y236-p
TRA2B (rat) GYDDRDYYSRSYrGG Y236
S237-p
yDDrDyysrSyrGGG
0 4
TRA2B (human) yDDrDyysrSyrGGG S237-p
TRA2B iso3 (human) YDDRDYYSRSYRGGG S137
TRA2B (mouse) YDDRDyySRSYrGGG S237
TRA2B (rat) YDDRDYYSRSYrGGG S237
R238-m1
DDrDyysrSyrGGGG
0 13
TRA2B (human) DDrDyysrSyrGGGG R238-m1
TRA2B iso3 (human) DDRDYYSRSYRGGGG R138
TRA2B (mouse) DDRDyySRSYrGGGG R238
TRA2B (rat) DDRDYYSRSYrGGGG R238
Y240-p
rDyysrSyrGGGGGG
0 1
TRA2B (human) rDyysrSyrGGGGGG Y240-p
TRA2B iso3 (human) RDYYSRSYRGGGGGG Y140
TRA2B (mouse) RDyySRSYrGGGGGG Y240
TRA2B (rat) RDYYSRSYrGGGGGG Y240
R241-m1
DyysrSyrGGGGGGG
0 76
TRA2B (human) DyysrSyrGGGGGGG R241-m1
TRA2B iso3 (human) DYYSRSYRGGGGGGG R141
TRA2B (mouse) DyySRSYrGGGGGGG R241-m1
TRA2B (rat) DYYSRSYrGGGGGGG R241-m1
R241-m2
DyysrSyrGGGGGGG
0 39
TRA2B (human) DyysrSyrGGGGGGG R241-m2
TRA2B iso3 (human) DYYSRSYRGGGGGGG R141
TRA2B (mouse) DyySRSYrGGGGGGG R241-m2
TRA2B (rat) DYYSRSYRGGGGGGG R241
R251-m1
GGGGGGWrAAQDrDQ
0 5
TRA2B (human) GGGGGGWrAAQDrDQ R251-m1
TRA2B iso3 (human) GGGGGGWRAAQDRDQ R151
TRA2B (mouse) GGGGGGWRAAQDRDQ R251
TRA2B (rat) GGGGGGWRAAQDRDQ R251
R256-m1
GWrAAQDrDQIyRRR
0 1
TRA2B (human) GWrAAQDrDQIyRRR R256-m1
TRA2B iso3 (human) GWRAAQDRDQIYRRR R156
TRA2B (mouse) GWRAAQDRDQIyRRR R256
TRA2B (rat) GWRAAQDRDQIYRRR R256
Y260-p
AQDrDQIyRRRsPsP
0 287
TRA2B (human) AQDrDQIyRRRsPsP Y260-p
TRA2B iso3 (human) AQDRDQIYRRRSPSP Y160
TRA2B (mouse) AQDRDQIyRRRsPsP Y260-p
TRA2B (rat) AQDRDQIYRRRsPsP Y260
S264-p
DQIyRRRsPsPyysr
Upstream
0 425
Treatment
  • metastatic potential
  • nocodazole
TRA2B (human) DQIyRRRsPsPyysr S264-p
TRA2B iso3 (human) DQIYRRRSPSPYYSR S164
TRA2B (mouse) DQIyRRRsPsPyysR S264-p
TRA2B (rat) DQIYRRRsPsPYYSR S264-p
S266-p
IyRRRsPsPyysrGG
Upstream
0 325
Treatment
  • EGF
  • metastatic potential
  • nocodazole
TRA2B (human) IyRRRsPsPyysrGG S266-p
TRA2B iso3 (human) IYRRRSPSPYYSRGG S166
TRA2B (mouse) IyRRRsPsPyysRGG S266-p
TRA2B (rat) IYRRRsPsPYYSRGG S266-p
Y268-p
RRRsPsPyysrGGyR
0 142
TRA2B (human) RRRsPsPyysrGGyR Y268-p
TRA2B iso3 (human) RRRSPSPYYSRGGYR Y168
TRA2B (mouse) RRRsPsPyysRGGYR Y268-p
TRA2B (rat) RRRsPsPYYSRGGYR Y268
Y269-p
RRsPsPyysrGGyRs
0 96
TRA2B (human) RRsPsPyysrGGyRs Y269-p
TRA2B iso3 (human) RRSPSPYYSRGGYRS Y169
TRA2B (mouse) RRsPsPyysRGGYRs Y269-p
TRA2B (rat) RRsPsPYYSRGGYRs Y269
S270-p
RsPsPyysrGGyRsR
Upstream
0 28
Treatment
  • nocodazole
TRA2B (human) RsPsPyysrGGyRsR S270-p
TRA2B iso3 (human) RSPSPYYSRGGYRSR S170
TRA2B (mouse) RsPsPyysRGGYRsR S270-p
TRA2B (rat) RsPsPYYSRGGYRsR S270
R271-m1
sPsPyysrGGyRsRs
0 3
TRA2B (human) sPsPyysrGGyRsRs R271-m1
TRA2B iso3 (human) SPSPYYSRGGYRSRS R171
TRA2B (mouse) sPsPyysRGGYRsRs R271
TRA2B (rat) sPsPYYSRGGYRsRs R271
Y274-p
PyysrGGyRsRsRsR
0 1
TRA2B (human) PyysrGGyRsRsRsR Y274-p
TRA2B iso3 (human) PYYSRGGYRSRSRSR Y174
TRA2B (mouse) PyysRGGYRsRsRsR Y274
TRA2B (rat) PYYSRGGYRsRsRsR Y274
S276-p
ysrGGyRsRsRsRsy
0 4
TRA2B (human) ysrGGyRsRsRsRsy S276-p
TRA2B iso3 (human) YSRGGYRSRSRSRSY S176
TRA2B (mouse) ysRGGYRsRsRsRsy S276-p
TRA2B (rat) YSRGGYRsRsRsRsY S276-p
S278-p
rGGyRsRsRsRsysP
Upstream
0 17
Treatment
  • nocodazole
TRA2B (human) rGGyRsRsRsRsysP S278-p
TRA2B iso3 (human) RGGYRSRSRSRSYSP S178
TRA2B (mouse) RGGYRsRsRsRsysP S278-p
TRA2B (rat) RGGYRsRsRsRsYsP S278-p
S280-p
GyRsRsRsRsysPRR
Upstream
0 22
Treatment
  • nocodazole
TRA2B (human) GyRsRsRsRsysPRR S280-p
TRA2B iso3 (human) GYRSRSRSRSYSPRR S180
TRA2B (mouse) GYRsRsRsRsysPRR S280-p
TRA2B (rat) GYRsRsRsRsYsPRR S280-p
S282-p
RsRsRsRsysPRRY_
Upstream
0 16
Treatment
  • nocodazole
TRA2B (human) RsRsRsRsysPRRY_ S282-p
TRA2B iso3 (human) RSRSRSRSYSPRRY_ S182
TRA2B (mouse) RsRsRsRsysPRRY_ S282-p
TRA2B (rat) RsRsRsRsYsPRRY_ S282-p
Y283-p
sRsRsRsysPRRY__
0 4
TRA2B (human) sRsRsRsysPRRY__ Y283-p
TRA2B iso3 (human) SRSRSRSYSPRRY__ Y183
TRA2B (mouse) sRsRsRsysPRRY__ Y283-p
TRA2B (rat) sRsRsRsYsPRRY__ Y283
S284-p
RsRsRsysPRRY___
0 22
TRA2B (human) RsRsRsysPRRY___ S284-p
TRA2B iso3 (human) RSRSRSYSPRRY___ S184
TRA2B (mouse) RsRsRsysPRRY___ S284-p
TRA2B (rat) RsRsRsYsPRRY___ S284-p